Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
166.5 USD | -0.70% | +4.68% | -7.80% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.80% | 9.37B | |
-4.07% | 185B | |
-0.54% | 109B | |
-3.53% | 68.54B | |
+4.62% | 51.74B | |
+10.27% | 45.22B | |
+3.12% | 41.74B | |
+4.24% | 26.83B | |
+3.84% | 26.69B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Sector Update: Health Care